姓名:郭春
性别:男
籍贯:辽宁阜新市
联系电话:024-43520226
E-Mail:gc_66888@163.com
职称/职务:教授
通讯地址:辽宁省本溪市高新技术产业开发区华佗大街26号,沈阳药科大学南校区27信箱
办公地点:制药楼228房间
教育经历:1985年毕业于沈阳药学院,获化学制药专业学士学位,1993年于同校获药物化学硕士学位,2002年同校获药物化学博士学位,1999.9~2001.8美国加州大学旧金山分校(UCSF)访学
工作经历:
1985.07-1987.12:东北制药总厂 助理工程师
1987.12-1993.07:沈阳药科大学 助教、讲师、副教授、教授博导
兼职情况:“基于靶点的药物设计与研究”教育部重点实验室常务副主任;药物化学实验中心主任; “天然活性物质的结构改造与类药性研究”教育部创新团队骨干成员。《中国药物化学杂志》、《沈阳药科大学学报》、《国外药学》、《中国医科大学学报》等杂志编委
学科/研究方向:抗感染药物研究、抗肿瘤药物研究、药物合成工艺设计与优化
科研/获奖情况:
近年来已完成国家、省、市纵向科研课题10余项,横向课题20余项。发表科研论文70余篇,主编、参编全国统编教材12部,出版译著1部;获授权发明专利10项。获国家级教学成果二等奖1项,省级教学成果二等奖5项。
教学/指导研究生情况:
为本科生主讲“药物化学”、“药物合成反应”等理论课,指导:“药物化学实验”“药物合成反应实验”;为硕士生讲授“药物化学专论”
已经培养(毕业)博士生8人,硕士生61人;目前指导博士研究生5人,硕士研究生15人
发表论文/出版著作:
代表性著作:
1.《药物合成反应》,人民卫生出版社,主编,2013.8
2.《药物合成反应实验》,中国医药科技出版社,主编,2015.2
3.《药物合成反应》,中国医药科技出版社,副主编,2012.8
4.《医药伦理学》(十一五规划教材),中国医药科技出版社,副主编,2012.7
5.《药物化学》(案例版),科学出版社,副主编,2010.3
6.《药物合成反应》(第三版)(十一五规划教材),化学工业出版社,参编,2013.7
7.《药物化学》(双语教材)(第二版),科学出版社,参编,2012.7
代表性论文:
1. Haonan Yu, Zhuang Hou, Ye Tian, Yanhua Mou **, Chun Guo , *Design, synthesis, cytotoxicity and mechanism of novel dihydroartemisinin-coumarin hybrids as potential anti-cancer agents, European Journal of Medicinal Chemistry , 2018,151:434-449 (IF=4.816)
2. Dan-Jiao Wanga,1, Zhuang Houa, 1, Hang Xua, Ran Ana, Xin Sub,*, Chun Guo,*Design, synthesis, and biological evaluation of 4-chloro-2H-thiochromenes featuring nitrogen- containing side chains as potent an agents. Bioorganic & Medicinal Chemistry Letters, (2018), doi: https://doi.org/10.1016/j.bmcl.2018.06.035 (IF=2.44)
3. Zhuang Hou a, 1, Bin Lin a, 1, Yu Bao b, Hai-ning Yan a, Miao Zhang a, Xiao-wei Chang a,
Xin-xin Zhang a, Zi-jie Wang a, Gao-fei Wei a, Mao-sheng Cheng a, Yang Liu a, *Chun Guo , **
Dual-tail approach to discovery of novel carbonic anhydrase IX inhibitors by simultaneously matching the hydrophobic and hydrophilic halves of the active site, European Journal of Medicinal Chemistry , 2017,132: 1-10(IF=3.9602)
4. Zhuang Hou, Yang Liu , Xin-xin Zhang, Xiao-wei Chang, Mao-sheng Cheng, Chun Guo* , Synthesis of glucuronic acid derivatives via the efficient and selective removal of aC6 methyl group, Tetrahedron Letters, 2017,58: 423–426(IF=2.347)
5.Chuan Du, Xiaoyu Wang, Shengfei Jin, HuiShi,YangmingLi,Yadong Pang, Yang Liu, Maosheng Cheng, Chun Guo,* and Yongxiang Liu*,Investigation of Meyer–Schuster Rearrangement Promoted bya Samarium(III) Triflate/N-Fluorobenzenesulfonimide Lewis AcidSystem, Asian J. Org. Chem. 2016, 5, 755. (IF=3.275)
6. Ye Tian , Zhen Liang , Hang Xu , YanhuaMou and Chun Guo ,* Design, Synthesis and Cytotoxicity of NovelDihydroartemisinin-Coumarin Hybrids viaClick Chemistry, Molecules, 2016, 21, 758.(IF=2.465)
7. Zhen Liang , Hang Xu , Ye Tian , MengbiGuo , Xin Su and Chun Guo ,* Design, Synthesis and Antifungal Activity of NovelBenzofuran-Triazole Hybrids, Molecules, 2016, 21, 732.(IF=2.465)
8. Qidong Tang, Yanfang Zhao, Xinming Du, Lian'e Chong, Ping Gong, Chun Guo*,Design, synthesis, and structure-–activity relationships of novel 6,7-disubstituted-4-phenoxyquinoline derivatives as potential antitumor agents,European Journal of Medicinal Chemistry, Volume 69, 2013, 77-89.(IF=3.499)
9. Wei Luo,Wei-Qiang Lu,Kun-QiangCui,YangLiu,Jian Wang Chun Guo* , N-{4- [(10S)- Dihydroartemisinin- 10-oxyl]}phenylmethyl-N- (2-methylquinoline-4-yl) hydrazine derivatives as falcipain-2 inhibitors,Med Chem Res,2012, 21:3073– 3079(IF=1.402)
10. Yang Liu, Wei Luo, Jian Wang, Jin Huang, Hong-lin L, Chun Guo*,Synthesis and biological activities of novel artemisinin derivatives as cysteine protease falcipain-2 inhibitors, Arch. Pharm. Res. 2012, 39(5):1525-31(IF=2.046)